Filing Details

Accession Number:
0001104659-23-007094
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-26 17:49:09
Reporting Period:
2023-01-25
Accepted Time:
2023-01-26 17:49:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1788028 Jasper Therapeutics Inc. JSPR American Depositary Receipts (8880) V8
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
889131 Ltd Holding Roche Grenzacherstrasse 124, 4070
Basel V8 CH-4070
No No Yes No
1053942 Ltd Finance Roche Grenzacherstrasse 124, 4070
Basel V8 CH-4070
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Voting Common Stock Disposition 2023-01-25 75,000 $1.89 4,549,606 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Footnotes
  1. Represents shares held by Roche Finance Ltd ("Roche Finance"). Roche Finance is a wholly owned subsidiary of Roche Holding Ltd ("Roche Holding"), a Swiss corporation whose shares are traded on the SIX Swiss Exchange. Roche Holding is the indirect beneficial owner of these securities of the Issuer. This Form 4 shall not be deemed an admission that any reporting person or other person is a beneficial owner of any securities of the Issuer for any purpose, other than the securities reported in this Form 4.